Article
Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma.
Cancer immunology research - 1 Oct 2015
Griesinger Andrea M, Josephson Rebecca J, Donson Andrew M, Mulcahy Levy Jean M, Amani Vladimir, Birks Diane K, Hoffman Lindsey M, Furtek Steffanie L, Reigan Phillip, Handler Michael H, Vibhakar Rajeev, Foreman Nicholas K
Abstract excerpt
Ependymoma (EPN) in childhood is a brain tumor with substantial mortality. Inflammatory response has been identified as a molecular signature of high-risk Group A EPN. To better understand the biology of this phenotype and aid therapeutic development, transcriptomic data from Group A and B EPN patient tumor samples, and additional malignant and normal brain data, were analyzed to identify the mechanism underlying...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
